Oral Excipients

Abstract Extended-release (ER) oral formulations provide therapeutic and practical benefits for pediatric patients by minimizing fluctuations in systemic exposure, reducing...

Abstract Oral dosage form development still relies heavily on empirical trial-and-error, while the high prevalence of poorly soluble drug candidates...

Abstract Background/Objectives. Warfarin possesses a bitter taste and requires a personalized dose in the range of 4.5 to 77 mg per...

Abstract Age-appropriate oral medicines remain limited for patients with swallowing difficulties, especially children. We present a chewable, drug delivery platform...

Abstract Oral delivery of peptides represents a promising alternative to invasive injectable therapies, offering improved patient adherence and convenience. Glucagon-like...

Abstract Oral drug delivery relies on precise, site-specific release within the gastrointestinal (GI) tract, commonly achieved using stimuli-responsive polymer (SRP)...

Abstract Background This study aimed to identify suitable excipients for the development of vitamin C orally disintegrating tablets (ODTs) using...

Abstract Contemporary small-molecule drug candidates increasingly have limited aqueous solubility, rendering oral delivery challenging. Amorphous solid dispersions (ASDs) and lipid-based...

Abstract The application of high-dose sulfasalazine (≥ 500  mg) followed by plasma or salivary sampling represents an established method for orocecal transit...

This poster has been presented at the 15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, which took place in...